Barely Significant
← all excerpts

Safety and Immunogenicity of the Nonavalent Human Papillomavirus Vaccine in Women Living with HIV.

Vaccines (Basel) · 2024 · PMC11359547 · PMID 39203964

Europe PMCDOI
1
hedged sentence
0.0080
closest p · 0.2× alpha
0.0080
boldest claim

The sentences

highly significantp = 0.008actually significant
A highly significant reduction in pain was observed between the first and third doses (54.1% vs. 38.5%, p = 0.008).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.